Hale Therapeutics provides a device and app to help people quit smoking by reducing nicotine intake gradually.
Hale Therapeutics has raised $2.0M in total funding. The most recent round was Seed. The last funding was announced in November 2021.
Hale Therapeutics's investors include Innovation Works, Michael Wells, Max Kanevsky, Mikal C Harden, Robert Keith.
Hale Therapeutics is headquartered in Philadelphia, United States.
Hale Therapeutics provides a device and app to help people quit smoking by reducing nicotine intake gradually.
Hale Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Hale Therapeutics — Funding & Investors." VCBacked, November 8, 2021, https://www.vcbacked.co/company/hale-therapeutics. Accessed October 30, 2026.
VCBacked. (2021). Hale Therapeutics — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/hale-therapeutics
{{cite web |title=Hale Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/hale-therapeutics |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated